CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-05 | Miller Larry Lee Chief Operating Officer | Grant or award · Restricted Stock Units | +300,000 | 300,000 | ||
| 2021-08-30 | CORCORAN E THOMAS Director | Purchase | +5,000 | $23.68 | $118K | 20,000 |
| 2021-02-09 | Miller Larry Lee Chief Operating Officer | Sale | −20,000 | $22.94 | $459K | 30,000 |
| 2021-02-08 | Miller Larry Lee Chief Operating Officer | Option exercise | +50,000 | 50,000 | ||
| 2021-02-08 | Miller Larry Lee Chief Operating Officer | Option exercise · Restricted Stock Units | −250,000 | 0 | ||
| 2019-08-30 | CORCORAN E THOMAS Director | Purchase | +5,000 | $21.21 | $106K | 15,000 |
| 2019-01-30 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,390 | $11.83 | $28K | 2,390 |
| 2019-01-30 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,390 | $31.15 | $74K | 0 |
| 2019-01-30 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,390 | 0 | ||
| 2019-01-29 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +4,890 | $11.83 | $58K | 4,890 |
| 2019-01-29 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −4,890 | $31.32 | $153K | 0 |
| 2019-01-29 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −4,890 | 2,390 | ||
| 2019-01-28 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-28 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $31.55 | $79K | 0 |
| 2019-01-28 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 7,280 | ||
| 2019-01-24 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-24 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $31.78 | $79K | 0 |
| 2019-01-24 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 9,780 | ||
| 2019-01-23 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-23 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −1,910 | $31.58 | $60K | 590 |
Page 10 of 18 · 343 trades